Published in
Elsevier, Lung Cancer, 3(82), p. 461-468
DOI: 10.1016/j.lungcan.2013.08.021
Links
Tools
A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 